UNSPSC 85392316: Diagnosis of placenta praevia

This classification denotes the group of activities that yields a diagnosis of Placenta praevia. Placenta praevia is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a three digit category under code O44

UNSPSC 85392316 Diagnosis of placenta praevia (Commodity) does not align with the state and local procurement activity currently posted under this code. The three recent opportunities on file — a diagnostic imaging PACS system from San Mateo Medical Center, ultrasound equipment procurement from Collier County, Florida, and phlebotomy services from the Albuquerque Police Department — address imaging infrastructure, diagnostic hardware, and laboratory specimen collection, none of which concern placenta praevia diagnosis specifically or obstetric ultrasound screening in clinical workflow. The code appears to be a taxonomy misapplication by issuing bodies tagging broader diagnostic imaging or clinical laboratory work with an overly specific placenta-related commodity code.

Recent activity spans California, Florida, and New Mexico, with no pattern of repeat buyers or geographic concentration. San Mateo Medical Center (RFP, due August 7, 2026) is the largest procurement by scope, seeking an enterprise PACS system to support 65,000 annual radiology studies, 5,000 cardiology studies, and 8,000 mammography interpretations with EPIC integration, 99.9% uptime, and a 9-to-12-month implementation window. Collier County issued a Notice of Intent to Single Source EchoNous ultrasound equipment (March 26, 2026), and the Albuquerque Police Department released an RFB for on-call phlebotomy services (due February 25, 2026). None of these opportunities directly solicit obstetric diagnostic services. If you are pursuing pregnancy-related diagnostic screening or maternal health imaging, this code shows little relevant recent activity; verify the actual commodity code used by target health systems and obstetric providers before investing in market development under this designation.